The long non-coding RNA-encoded microprotein MKKS3 drives colorectal cancer chemoresistance

Hui-Fang Hu, Qi Zhou, Jia-Zhen Huang, Jia-Ying Fu, Zhi-Ting Zuo, Qing-Yu He · 2026

Read The long non-coding RNA-encoded microprotein MKKS3 drives colorectal cancer chemoresistance by Hui-Fang Hu, Qi Zhou, Jia-Zhen Huang, Jia-Ying Fu, Zhi-Ting Zuo, Qing-Yu He (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13633250.txt.

Description

Hui-Fang Hu and five co-authors found a tiny protein that helps colon cancer resist a front-line drug, in a study published in 2026. The protein hides in a text long classed as non-coding. A gene hunt that cut each of 314 such small proteins in turn flagged this one as the drug shield. Wide scans found it in many cancer types.

In cells it does two jobs: it helps repair DNA damage, and it tags a cell alarm for destruction, which mutes the immune call. Gut wall cells then shift to a form that pours out a suppressive growth broth, which deepens the shield. A plant compound breaks its key grip, and paired with the drug it worked far better in tests. Gene-silencing shots plus the drug did the same in mice.

Catalog record

CREATORHui-Fang Hu, Qi Zhou, Jia-Zhen Huang, Jia-Ying Fu, Zhi-Ting Zuo, Qing-Yu He
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE96 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13633250

Browse the full library · About the Tower of Babel